2017年第4版NCCN卵巢癌临床实践指南解读

Interpretation of version 4.2017 of NCCN clinical practice guidelines for ovarian cancer

卵巢恶性肿瘤是女性生殖器官常见的恶性肿瘤之一,发病率仅次于子宫颈癌和子宫体癌而列居第3位,但其死亡率居各类妇科肿瘤首位,对妇女生命健康造成严重威胁。近年来美国国立综合癌症网络(National Comprehensive Cancer Network)发布的NCCN卵巢癌临床实践指南已成为卵巢癌诊治的重要依据之一。为更好地将其应用于临床,该文对新版指南进行了简要解读。

Ovarian cancer is one of the common malignant tumors of female genital organs. In gynecological tumors, the incidence rate of ovarian cancer ranks the third after cervical cancer and uterine body cancer, but the death rate of ovarian cancer ranks the first, posing a serious threat to women＇s life and health. In recent years, the National Comprehensive Cancer Network （NCCN） clinical practice guidelines for ovarian cancer has become an important basis for diagnosis and treatment of ovarian cancer. In this paper, we interpret the latest version （version 4.2017） of NCCN clinical practice guidelines for ovarian cancer for its better clinical application.